These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 553082)

  • 1. Effect of niridazole and niridazole immunoregulatory factor (NIF) on cutaneous delayed hypersensitivity in mice.
    Blumer JL; Simpson JM; Lucas SV; Webster LT
    Immunopharmacology; 1979 Dec; 2(1):51-61. PubMed ID: 553082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Keto niridazole: a major niridazole metabolite with central nervous system toxicity different than niridazole.
    Catto BA; Valencia CI; Hafez K; Fairchild EH; Webster LT
    J Pharmacol Exp Ther; 1984 Mar; 228(3):662-8. PubMed ID: 6707915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niridazole, a potent long-acting suppressant of cellular hypersensitivity. III. Minimal suppression of antibody responses.
    Pelley RP; Pelley RJ; Stavitsky AB; Mahmoud AA; Warren KS
    J Immunol; 1975 Dec; 115(6):1477-82. PubMed ID: 1184961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niridazole-mediated modulation of suppressor cells in Wistar rats.
    Sainis KB; Gadgil MB; Phondke GP
    Immunopharmacology; 1984 Oct; 8(2):61-8. PubMed ID: 6239839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of N-(5-nitro-2-thiazolyl)-N'-carboxymethylurea from 5-hydroxyniridazole. Role of aldehyde dehydrogenase in the oxidative metabolism of niridazole.
    Tracy JW; Catto BA; Webster LT
    Drug Metab Dispos; 1991; 19(2):508-15. PubMed ID: 1676663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of the induction phase of delayed type hypersensitivity in mice by niridazole.
    Vadas MA; Bernard CC
    Clin Immunol Immunopathol; 1981 Sep; 20(3):313-20. PubMed ID: 6210477
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice.
    Legator MS; Connor TH; Stoeckel M
    Science; 1975 Jun; 188(4193):1118-9. PubMed ID: 766186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea-pigs. IV. failure to inhibit mononuclear cell accumulation with niridazole.
    Rudofsky UH; Pollara B
    Clin Exp Immunol; 1977 Mar; 27(3):522-5. PubMed ID: 862238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole.
    Webster LT; Butterworth AE; Mahmoud AA; Mngola EN; Warren KS
    N Engl J Med; 1975 May; 292(22):1144-7. PubMed ID: 1124104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole.
    Daniels JC; Warren KS; David JR
    J Immunol; 1975 Nov; 115(5):1414-21. PubMed ID: 51891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the mixed lymphocyte reaction by fractionated niridazole urine dialysate.
    Jones BM; Bird M; Griffin PJ; Massey PR; Millar DA; Miller JJ; Reeves S; Salaman JR
    J Immunol; 1979 Jul; 123(1):143-5. PubMed ID: 156231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of delayed hypersensitivity to sheep erythrocytes by niridazole.
    Sainis KB; Gadgil MB; Phondke GP
    Indian J Exp Biol; 1983 Jun; 21(6):304-9. PubMed ID: 6667984
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicogenetics of niridazole in inbred mice.
    Blumer JL; Simpson JM; Lucas SV; Webster LT
    J Pharmacol Exp Ther; 1980 Mar; 212(3):509-13. PubMed ID: 7359350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity.
    Mahmoud AA; Mandel A; Warren K; Webster LT
    J Immunol; 1975 Jan; 114(1 Pt 2):279-83. PubMed ID: 1090648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent binding of niridazole (Ambilhar) to tissue proteins of the rat.
    Oduah IN; Thabrew MI; Emerole GO
    Chem Biol Interact; 1984 May; 49(3):299-310. PubMed ID: 6722942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the immunosuppressive drug niridazole in isogeneic and allogeneic mouse tumor systems in vivo.
    Deodhar SD; Lee VW; Chiang T; Mahmoud AF; Watten KS
    Cancer Res; 1976 Sep; 36(9 pt.1):3147-50. PubMed ID: 975080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of niridazole by metronidazole resistant and susceptible strains of Trichomonas vaginalis.
    Yarlett N; Rowlands CC; Yarlett NC; Evans JC; Lloyd D
    Parasitology; 1987 Feb; 94 ( Pt 1)():93-9. PubMed ID: 3029651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formation of 1-thiocarbamoyl-2-imidazolidinone from niridazole in mouse intestine.
    Tracy JW; Webster LT
    J Pharmacol Exp Ther; 1981 May; 217(2):363-8. PubMed ID: 6894465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerobic metabolism of niridazole by rat liver microsomes.
    Blumer JL; Novak RF; Lucas SV; Simpson JM; Webster LT
    Mol Pharmacol; 1979 Nov; 16(3):1019-30. PubMed ID: 119155
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of niridazole in cellular immunity in vivo and in vitro.
    Solbach W; Wagner H; Röllinghoff M
    Clin Exp Immunol; 1978 Jun; 32(3):411-8. PubMed ID: 357051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.